[1] FENG JH,QIAN Y.Advances in research on childhood neutropenia[J].Chin J Contemp Pediatr(中国当代儿科杂志), 2017, 19(4): 484-489. [2] KESARWALA HH, RAHILL WJ, AMARAM N.Vancomycin induced neutropenia[J].Lancet, 1981, 317(8235): 1423. [3] SHINOHARA YT, COLBERT J.Vancomycin-induced neutropenia during treatment of endocarditis in a pediatric patient[J]. Ann Pharmacother, 1994, 28(6): 723-726. [4] JI HH,LUO J,SONG L,et al.Analysis of vancomycin-induced neutropenia adverse reactions/adverse events in children[J]. China Pharmacy(中国药房), 2016, 27(6): 760-762. [5] CHENG GY, MA Z, JIANG Q, et al.Case analysis of vancomycin-induced febrile neutropenia in a child[J]. Chinese Journal of Drug Application and Monitoring(中国药物应用与监测), 2019, 16(4): 253-255. [6] NARANJO CA, BUSTO U, SELLERS EM, et al.A method for estimating the probability of adverse drug reactions[J]. Clin Pharmacol Ther, 1981, 30(2): 239-245. [7] Center for Drug Reevaluation. Provisions for Adverse Drug Reaction Reporting and Monitoring(《药品不良反应报告和监测管理办法》培训教材)[M]. 2015 edition.Beijing: China Medical Science and Press, 2012. [8] LIU LY, LI Y, GU SY.Retrospective analysis of 38 granulocytopenia cases induced by vancomycin[J]. Chinese Journal of Pharmacovigilance(中国药物警戒) , 2012, 9(2): 117-118. [9] BLACK E, LAU TT, ENSOM MH.Vancomycin-induced neutropenia: is it dose- or duration-related?[J]. Ann Pharmacother, 2011, 45(5): 629-638. [10] SCHWARTZ MD.Vancomycin-induced neutropenia in a patient positive for an antineutrophil antibody[J].Pharmacotherapy, 2002, 22(6): 783-788. [11] SMITH PF,TAYLOR CT.Vancomycin-induced neutropenia associated with fever: similarities between two immune-mediated drug reactions[J]. Pharmacotherapy, 1999, 19(2): 240-244. [12] ROCHA JL, KONDO W, BAPTISTA MI, et al.Uncommon vancomycin-induced side effects[J]. Braz J Infect Dis, 2002, 6(4): 196-200. [13] HE N, SU S, YE Z, et al.Evidence-based guideline for therapeutic drug monitoring of vancomycin: 2020 update by the division of therapeutic drug monitoring, chinese pharmacological society[J].Clin Infect Dis, 2020, 71(Suppl 4): S363-S371. |